A buyer can ask about a dermatology practice sale long before you decide to sell. The useful first step is not a price quote. It is a file that separates payer revenue from cosmetic cash pay, shows production by provider, and explains Mohs and other ancillary lines.
That file does not force a sale. It lets you see the practice the way a careful buyer will see it. First Move Advisors helps owners build that view before a broker or buyer sets the frame. The firm is not a broker and not a buyer.
What Should You Organize Before a Dermatology Practice Sale?
Start with four groups of records. Keep them separate even if your monthly report blends them today.
- Payer revenue and cosmetic cash-pay revenue, shown as their own lines.
- Production by provider, including physicians and advanced practice clinicians.
- Mohs, pathology, and any other ancillary line, with its own volume and margin notes.
- The clinical and compliance documents that explain how those lines are delivered.
A general medical checklist is a start, not the file. Dermatology mixes insured medical care, surgery, and cash-pay cosmetic work. Buyers read those lines differently. If the totals are blended, the first meeting turns into a reconstruction project.
You do not need a finished data room on day one. You need source reports an owner, a CPA, and counsel can trace. A later healthcare practice data room checklist is easier to build from clean source files than from a single year-end PDF.
Give each group a folder name you will still understand in six months. "Revenue by line," "providers," "Mohs and ancillaries," and "licenses and contracts" are enough. Put the export date on every report. A buyer who cannot tell March from a later rerun will ask for the work again.
How Should You Separate Payer and Cosmetic Revenue?
Pull at least three years of collections, and the current year to date. Split every dollar into a line a buyer can name. Medical visits, surgical procedures, Mohs, pathology, retail product, and cosmetic services should not share one bucket called "other."
Cosmetic work often arrives as cash pay. That can make a practice less dependent on insurers than a specialty with little self-pay. It also raises questions. Is the cosmetic book tied to one physician's name and injector skill? Did a promotion, a new device, or a departed provider create a spike? Can the schedule stay full if that person steps back?
Payer revenue needs the other side of the story. List the top payers by collections, not just by charge. Note denial patterns, slow accounts, and any contract that is up for renewal. A buyer is testing whether the insured book repeats, not whether last year's charges looked large.
Keep a short bridge from the practice management report to the financial statements. If collections in the billing system do not match revenue in the books, write the reason in one paragraph. Timing, refunds, and payment plans are ordinary. Silence about the gap is what slows diligence.
Add one page on price changes. If cosmetic fees, a new laser, or a payer rate shift moved collections, note the month it started. Buyers try to tell a lasting change from a one-season bump. You will remember the reason now. You may not remember it after a year of meetings.
| Line | What to pull | Question the file should answer |
|---|---|---|
| Insured medical and surgical | Collections by payer and by CPT group | Is the book concentrated in a few plans? |
| Cosmetic and retail | Cash-pay collections by service and by provider | Does this line travel with one clinician? |
| Mohs and pathology | Case volume, site of service, and related collections | Is the line inside the practice or outside it? |
| Adjustments | Owner pay, one-time costs, and related-party rent | Which items are documented, not hoped for? |
What Does Provider Production Tell a Buyer?
Buyers rarely underwrite "the practice" as one person. They look at who produces the work, who supervises it, and who is likely to stay. Build a simple production sheet for each physician and each advanced practice clinician.
Show visits or cases, collections, and the share of cosmetic versus insured work. Add the employment or contractor status, the remaining term, and any notice period. If a non-compete or a non-solicit exists, note that it needs legal review. Do not guess whether it will hold.
A published claims study found that private-equity-owned dermatology practices employed more advanced practice clinicians per dermatologist than other practices. And that patient volume per dermatologist was higher after acquisition. The same study did not find a consistent change in biopsies, lesion destruction, or Mohs use. Read the abstract in Health Affairs via PubMed. The point for an owner is practical. A buyer will ask how advanced practice clinicians are supervised and how production is assigned. Have that answer in the file before the question arrives.
Also mark founder dependence in plain language. If one dermatologist generates most cosmetic revenue, say so and describe the handover you would accept. A smaller, well-explained concentration is easier to discuss than a surprise in month three of diligence.
Staff stability belongs on the same sheet. List tenure for the office manager, the lead biller, and the Mohs team if you have one. A buyer is not collecting biographies. They are asking whether the people who know the schedule and the claims will still be there after closing. Vacancies and recent turnover deserve one honest line.
How Should Mohs and Ancillary Lines Be Documented?
Mohs, in-office pathology, a med spa, and product sales can make a dermatology practice look broader than a visit-only clinic. They also create separate proof problems. Treat each line as its own mini file.
For Mohs, collect case counts, who performs the surgery, where it is done, and how pathology is read. Note lab ownership, outside lab contracts, and any medical-director arrangement. If a surgery suite or an ambulatory center sits beside the clinic, list the entity, the owners, and whether the real estate is in the same sale.
For pathology and product sales, show revenue, cost, and who bills. A line that looks profitable in a management report can shrink once outside lab fees, device leases, or inventory are matched to it. Write those costs next to the revenue. Buyers do this match anyway.
Clinical trials and research stipends belong here too, if you have them. They are not ordinary visit revenue. Label the contract, the term, and whether the payment continues after a sale. Leaving them inside "other income" invites a cut later.
None of this is a valuation. Multiples move with earnings quality, scale, and structure, and two offers at the same stated multiple can pay very different cash at close. Keep the conversation on records you can support. Your CPA is the right person to test any add-back.
Which Clinical Documents Support the Numbers?
Numbers without a delivery story do not survive diligence. Pair the revenue file with the documents that show how care is staffed and supervised.
- Active licenses, DEA registrations, and board certificates for each clinician.
- Supervision and collaboration agreements for advanced practice clinicians.
- Payer enrollment and credentialing status, including any plan that is pending.
- Lab, device, and pathology contracts, plus the leases for rooms and lasers.
- A short description of how the record system stores photos, pathology, and visit notes.
Buyers use this set to test continuity. They want to know the clinic can keep seeing patients if the legal owner changes. Gaps here become conditions, delays, or price talks. They are cheaper to list now than to discover under a deadline.
Privacy still applies while you prepare. Do not export patient names, photos, or full charts into a shared folder. Summaries and de-identified samples are enough until counsel sets the release rules. The broader medical file is covered in what to prepare for medical practice due diligence. Use that piece for licenses and contracts in general. Use this one for the dermatology lines it does not split out.
Why Does This File Matter Before You Talk to Buyers?
Dermatology has been an active acquisition specialty for years. A JAMA Dermatology study counted 184 practices acquired by 17 private-equity-backed dermatology management groups from May 2012 through May 2018. Those deals covered an estimated 381 clinics in at least 30 states. The PubMed record is Trends in Private Equity Acquisition of Dermatology Practices. Interest from buyers is not a reason to accept the first conversation.
An early file lets you choose the timing. You might want a later sale, a period of independence, or a clearer view of cosmetic concentration before any outreach. Preparation does not commit you. It keeps a flattering story, or a worrying one, from being the only story in the room.
It also protects the earnings discussion. Owner compensation, one-time expenses, and related-party rent should be listed with support, not asserted. Normalized EBITDA for a healthcare practice explains that bridge. Your dermatology file supplies the revenue split that a general bridge cannot see.
When the records are readable, you can decide whether a buyer, a broker, or neither belongs in the next step. How preparation works describes a free first conversation and a fixed-fee diagnostic you own, with no listing agreement. That is a different job from running a sale.
What Can Wait Until You Are Closer to a Process?
Some work is real and still premature. Buyer lists, teaser language, and a full virtual room can wait until you know you want outreach. So can debates about earnouts, rollover equity, and cash at close. Those terms matter, and they are easier to judge after the revenue lines are clean.
If you want the sequence of a transaction without turning this into a sale manual, read practice sale stages and documents. For a physician checklist that is not dermatology-specific, see what to organize before selling a medical practice. Come back to payer mix, cosmetic concentration, Mohs, and provider production before you reuse a general list.
A pain, ENT, or urology practice has its own lines. Do not copy those checklists into a dermatology file. The pattern is the same only at the top: separate the work buyers will price. Name the people who produce it, and keep clinical proof next to the numbers.
Frequently Asked Questions
Do I need to sell because buyers are calling?
No. A call is not a deadline. Independence is a valid choice. A clean file helps you decide whether a later sale, a hold, or a conversation is the better next step.
How far back should dermatology revenue records go?
Three full years plus the current year to date is a practical start. Split payer, cosmetic, Mohs, pathology, and retail. Add a one-paragraph bridge wherever the billing report and the books disagree.
Should cosmetic revenue be presented as more valuable?
Not by default. Cash-pay work can diversify the book, and it can also depend on one provider. Show who performs it and whether the demand is repeatable. Let the evidence, not a slogan, carry the point.
What if Mohs is performed through a separate entity?
Say that clearly. List the entity, the owners, the site of service, and whether the real estate or the lab is included. Buyers will ask. A separate entity is not a problem. An unexplained one is.
When should staff and patients be told?
Not during early preparation. Build the file quietly, and decide on any announcement with counsel when a real process exists. Early rumors distract the clinic and rarely help the outcome.
Start With the File, Not the Offer
A dermatology practice sale goes better when the owner can explain the book without scrambling. Separate payer and cosmetic revenue. Show production by provider. Document Mohs and the other ancillary lines. Keep the clinical papers that make those numbers believable.
You can do that work years before a sale, or not sell at all. If you want a low-pressure look at the file with someone who has sat on the buyer side, schedule a free consultation with First Move Advisors. David and Eric will talk through marketability and the practical next step. There is no pitch and no obligation to proceed.